APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Analgesic Gel Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global OTC Analgesic Gel Drug Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchOTC Analgesic Gel Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Analgesic Gel Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal OTC Analgesic Gel Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Analgesic Gel Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Analgesic Gel Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global OTC Analgesic Gel Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for OTC Analgesic Gel Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Analgesic Gel Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Analgesic Gel Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the OTC Analgesic Gel Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the OTC Analgesic Gel Drug market include China Biopharmaceutical Co., Ltd., Jiangsu Innovent Biologics Co., Ltd., Job Care Pharmaceutical Group Co., Ltd., Hunan Jiudian Pharmaceutical Co., Ltd., Teikoku Pharma, RB Health, PERNATON, MIKASA SEIYAKU CO.,LTD and Lead Chemical CO., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global OTC Analgesic Gel Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Analgesic Gel Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Analgesic Gel Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global OTC Analgesic Gel Drug market.

OTC Analgesic Gel Drug Segment by Company

China Biopharmaceutical Co., Ltd.

Jiangsu Innovent Biologics Co., Ltd.

Job Care Pharmaceutical Group Co., Ltd.

Hunan Jiudian Pharmaceutical Co., Ltd.

Teikoku Pharma

RB Health

PERNATON

MIKASA SEIYAKU CO.,LTD

Lead Chemical CO., Ltd

Kowa Company

Haleon

OTC Analgesic Gel Drug Segment by Type

Patches

Ointments

OTC Analgesic Gel Drug Segment by Application

Online Sales

Offline Sales

OTC Analgesic Gel Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global OTC Analgesic Gel Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the OTC Analgesic Gel Drug key companies, revenue, market share, and recent developments.

3. To split the OTC Analgesic Gel Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions OTC Analgesic Gel Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify OTC Analgesic Gel Drug significant trends, drivers, influence factors in global and regions.

6. To analyze OTC Analgesic Gel Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Analgesic Gel Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Analgesic Gel Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Analgesic Gel Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Analgesic Gel Drug industry.

Chapter 3: Detailed analysis of OTC Analgesic Gel Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of OTC Analgesic Gel Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of OTC Analgesic Gel Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. OTC Analgesic Gel Drug Industry Trends Table 2. OTC Analgesic Gel Drug Industry Drivers Table 3. OTC Analgesic Gel Drug Industry Opportunities and Challenges Table 4. OTC Analgesic Gel Drug Industry Restraints Table 5. Global OTC Analgesic Gel Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global OTC Analgesic Gel Drug Revenue Share by Company (2021-2026) Table 7. Global OTC Analgesic Gel Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global OTC Analgesic Gel Drug Key Company Manufacturing Base & Headquarters Table 9. Global OTC Analgesic Gel Drug Company, Product Type & Application Table 10. Global OTC Analgesic Gel Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global OTC Analgesic Gel Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Patches Table 15. Significant Companies of Ointments Table 16. Global OTC Analgesic Gel Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global OTC Analgesic Gel Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global OTC Analgesic Gel Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global OTC Analgesic Gel Drug Sales Value Share by Type (2021-2026) Table 20. Global OTC Analgesic Gel Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Online Sales Table 22. Significant Companies of Offline Sales Table 23. Global OTC Analgesic Gel Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global OTC Analgesic Gel Drug Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global OTC Analgesic Gel Drug Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global OTC Analgesic Gel Drug Sales Value Share by Application (2021-2026) Table 27. Global OTC Analgesic Gel Drug Sales Value Share by Application (2027-2032) Table 28. Global OTC Analgesic Gel Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global OTC Analgesic Gel Drug Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global OTC Analgesic Gel Drug Sales Value Share by Region (2021-2026) Table 31. Global OTC Analgesic Gel Drug Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global OTC Analgesic Gel Drug Sales Value Share by Region (2027-2032) Table 33. Global OTC Analgesic Gel Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global OTC Analgesic Gel Drug Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global OTC Analgesic Gel Drug Sales Value Market Share by Country (2021-2026) Table 36. Global OTC Analgesic Gel Drug Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global OTC Analgesic Gel Drug Sales Value Market Share by Country (2027-2032) Table 38. China Biopharmaceutical Co., Ltd. Company Information Table 39. China Biopharmaceutical Co., Ltd. Business Overview Table 40. China Biopharmaceutical Co., Ltd. OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. China Biopharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio Table 42. China Biopharmaceutical Co., Ltd. Recent Development Table 43. Jiangsu Innovent Biologics Co., Ltd. Company Information Table 44. Jiangsu Innovent Biologics Co., Ltd. Business Overview Table 45. Jiangsu Innovent Biologics Co., Ltd. OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Jiangsu Innovent Biologics Co., Ltd. OTC Analgesic Gel Drug Product Portfolio Table 47. Jiangsu Innovent Biologics Co., Ltd. Recent Development Table 48. Job Care Pharmaceutical Group Co., Ltd. Company Information Table 49. Job Care Pharmaceutical Group Co., Ltd. Business Overview Table 50. Job Care Pharmaceutical Group Co., Ltd. OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Job Care Pharmaceutical Group Co., Ltd. OTC Analgesic Gel Drug Product Portfolio Table 52. Job Care Pharmaceutical Group Co., Ltd. Recent Development Table 53. Hunan Jiudian Pharmaceutical Co., Ltd. Company Information Table 54. Hunan Jiudian Pharmaceutical Co., Ltd. Business Overview Table 55. Hunan Jiudian Pharmaceutical Co., Ltd. OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Hunan Jiudian Pharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio Table 57. Hunan Jiudian Pharmaceutical Co., Ltd. Recent Development Table 58. Teikoku Pharma Company Information Table 59. Teikoku Pharma Business Overview Table 60. Teikoku Pharma OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Teikoku Pharma OTC Analgesic Gel Drug Product Portfolio Table 62. Teikoku Pharma Recent Development Table 63. RB Health Company Information Table 64. RB Health Business Overview Table 65. RB Health OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. RB Health OTC Analgesic Gel Drug Product Portfolio Table 67. RB Health Recent Development Table 68. PERNATON Company Information Table 69. PERNATON Business Overview Table 70. PERNATON OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. PERNATON OTC Analgesic Gel Drug Product Portfolio Table 72. PERNATON Recent Development Table 73. MIKASA SEIYAKU CO.,LTD Company Information Table 74. MIKASA SEIYAKU CO.,LTD Business Overview Table 75. MIKASA SEIYAKU CO.,LTD OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. MIKASA SEIYAKU CO.,LTD OTC Analgesic Gel Drug Product Portfolio Table 77. MIKASA SEIYAKU CO.,LTD Recent Development Table 78. Lead Chemical CO., Ltd Company Information Table 79. Lead Chemical CO., Ltd Business Overview Table 80. Lead Chemical CO., Ltd OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Lead Chemical CO., Ltd OTC Analgesic Gel Drug Product Portfolio Table 82. Lead Chemical CO., Ltd Recent Development Table 83. Kowa Company Company Information Table 84. Kowa Company Business Overview Table 85. Kowa Company OTC Analgesic Gel Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Kowa Company OTC Analgesic Gel Drug Product Portfolio Table 87. Kowa Company Recent Development Table 88. Haleon Company Information Table 89. Haleon Business Overview Table 90. Haleon OTC Analgesic Gel Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Haleon OTC Analgesic Gel Drug Product Portfolio Table 92. Haleon Recent Development Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. OTC Analgesic Gel Drug Product Image Figure 2. Global OTC Analgesic Gel Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Analgesic Gel Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Analgesic Gel Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Patches Image Figure 8. Ointments Image Figure 9. Global OTC Analgesic Gel Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global OTC Analgesic Gel Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global OTC Analgesic Gel Drug Sales Value Share by Type (2021-2032) Figure 12. Online Sales Image Figure 13. Offline Sales Image Figure 14. Global OTC Analgesic Gel Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global OTC Analgesic Gel Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global OTC Analgesic Gel Drug Sales Value Share by Application (2021-2032) Figure 17. Global OTC Analgesic Gel Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global OTC Analgesic Gel Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America OTC Analgesic Gel Drug Sales Value (2021-2032) & (US$ Million) Figure 20. North America OTC Analgesic Gel Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe OTC Analgesic Gel Drug Sales Value (2021-2032) & (US$ Million) Figure 22. Europe OTC Analgesic Gel Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific OTC Analgesic Gel Drug Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific OTC Analgesic Gel Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America OTC Analgesic Gel Drug Sales Value (2021-2032) & (US$ Million) Figure 26. South America OTC Analgesic Gel Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa OTC Analgesic Gel Drug Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa OTC Analgesic Gel Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Patches
  • Ointments
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • China Biopharmaceutical Co., Ltd.
  • Jiangsu Innovent Biologics Co., Ltd.
  • Job Care Pharmaceutical Group Co., Ltd.
  • Hunan Jiudian Pharmaceutical Co., Ltd.
  • Teikoku Pharma
  • RB Health
  • PERNATON
  • MIKASA SEIYAKU CO.,LTD
  • Lead Chemical CO., Ltd
  • Kowa Company
  • Haleon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Analgesic Gel Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Analgesic Gel Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 OTC Analgesic Gel Drug Market Dynamics
  1. 2.1 OTC Analgesic Gel Drug Industry Trends
  2. 2.2 OTC Analgesic Gel Drug Industry Drivers
  3. 2.3 OTC Analgesic Gel Drug Industry Opportunities and Challenges
  4. 2.4 OTC Analgesic Gel Drug Industry Restraints
3 OTC Analgesic Gel Drug Market by Company
  1. 3.1 Global OTC Analgesic Gel Drug Company Revenue Ranking in 2025
  2. 3.2 Global OTC Analgesic Gel Drug Revenue by Company (2021-2026)
  3. 3.3 Global OTC Analgesic Gel Drug Company Ranking (2024-2026)
  4. 3.4 Global OTC Analgesic Gel Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global OTC Analgesic Gel Drug Company Product Type and Application
  6. 3.6 Global OTC Analgesic Gel Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global OTC Analgesic Gel Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 OTC Analgesic Gel Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 OTC Analgesic Gel Drug Market by Type
  1. 4.1 OTC Analgesic Gel Drug Type Introduction
  2. 4.1.1 Patches
  3. 4.1.2 Ointments
  4. 4.2 Global OTC Analgesic Gel Drug Sales Value by Type
  5. 4.2.1 Global OTC Analgesic Gel Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global OTC Analgesic Gel Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global OTC Analgesic Gel Drug Sales Value Share by Type (2021-2032)
5 OTC Analgesic Gel Drug Market by Application
  1. 5.1 OTC Analgesic Gel Drug Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global OTC Analgesic Gel Drug Sales Value by Application
  5. 5.2.1 Global OTC Analgesic Gel Drug Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global OTC Analgesic Gel Drug Sales Value by Application (2021-2032)
  7. 5.2.3 Global OTC Analgesic Gel Drug Sales Value Share by Application (2021-2032)
6 OTC Analgesic Gel Drug Regional Value Analysis
  1. 6.1 Global OTC Analgesic Gel Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Analgesic Gel Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global OTC Analgesic Gel Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global OTC Analgesic Gel Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Analgesic Gel Drug Sales Value (2021-2032)
  7. 6.3.2 North America OTC Analgesic Gel Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe OTC Analgesic Gel Drug Sales Value (2021-2032)
  10. 6.4.2 Europe OTC Analgesic Gel Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific OTC Analgesic Gel Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific OTC Analgesic Gel Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America OTC Analgesic Gel Drug Sales Value (2021-2032)
  16. 6.6.2 South America OTC Analgesic Gel Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa OTC Analgesic Gel Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa OTC Analgesic Gel Drug Sales Value Share by Country, 2025 VS 2032
7 OTC Analgesic Gel Drug Country-level Value Analysis
  1. 7.1 Global OTC Analgesic Gel Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global OTC Analgesic Gel Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global OTC Analgesic Gel Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global OTC Analgesic Gel Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt OTC Analgesic Gel Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt OTC Analgesic Gel Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt OTC Analgesic Gel Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 China Biopharmaceutical Co., Ltd.
  2. 8.1.1 China Biopharmaceutical Co., Ltd. Company Information
  3. 8.1.2 China Biopharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 China Biopharmaceutical Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 China Biopharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
  6. 8.1.5 China Biopharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Jiangsu Innovent Biologics Co., Ltd.
  8. 8.2.1 Jiangsu Innovent Biologics Co., Ltd. Company Information
  9. 8.2.2 Jiangsu Innovent Biologics Co., Ltd. Business Overview
  10. 8.2.3 Jiangsu Innovent Biologics Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Innovent Biologics Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
  12. 8.2.5 Jiangsu Innovent Biologics Co., Ltd. Recent Developments
  13. 8.3 Job Care Pharmaceutical Group Co., Ltd.
  14. 8.3.1 Job Care Pharmaceutical Group Co., Ltd. Company Information
  15. 8.3.2 Job Care Pharmaceutical Group Co., Ltd. Business Overview
  16. 8.3.3 Job Care Pharmaceutical Group Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Job Care Pharmaceutical Group Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
  18. 8.3.5 Job Care Pharmaceutical Group Co., Ltd. Recent Developments
  19. 8.4 Hunan Jiudian Pharmaceutical Co., Ltd.
  20. 8.4.1 Hunan Jiudian Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Hunan Jiudian Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Hunan Jiudian Pharmaceutical Co., Ltd. OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hunan Jiudian Pharmaceutical Co., Ltd. OTC Analgesic Gel Drug Product Portfolio
  24. 8.4.5 Hunan Jiudian Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Teikoku Pharma
  26. 8.5.1 Teikoku Pharma Company Information
  27. 8.5.2 Teikoku Pharma Business Overview
  28. 8.5.3 Teikoku Pharma OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teikoku Pharma OTC Analgesic Gel Drug Product Portfolio
  30. 8.5.5 Teikoku Pharma Recent Developments
  31. 8.6 RB Health
  32. 8.6.1 RB Health Company Information
  33. 8.6.2 RB Health Business Overview
  34. 8.6.3 RB Health OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 RB Health OTC Analgesic Gel Drug Product Portfolio
  36. 8.6.5 RB Health Recent Developments
  37. 8.7 PERNATON
  38. 8.7.1 PERNATON Company Information
  39. 8.7.2 PERNATON Business Overview
  40. 8.7.3 PERNATON OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PERNATON OTC Analgesic Gel Drug Product Portfolio
  42. 8.7.5 PERNATON Recent Developments
  43. 8.8 MIKASA SEIYAKU CO.,LTD
  44. 8.8.1 MIKASA SEIYAKU CO.,LTD Company Information
  45. 8.8.2 MIKASA SEIYAKU CO.,LTD Business Overview
  46. 8.8.3 MIKASA SEIYAKU CO.,LTD OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MIKASA SEIYAKU CO.,LTD OTC Analgesic Gel Drug Product Portfolio
  48. 8.8.5 MIKASA SEIYAKU CO.,LTD Recent Developments
  49. 8.9 Lead Chemical CO., Ltd
  50. 8.9.1 Lead Chemical CO., Ltd Company Information
  51. 8.9.2 Lead Chemical CO., Ltd Business Overview
  52. 8.9.3 Lead Chemical CO., Ltd OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lead Chemical CO., Ltd OTC Analgesic Gel Drug Product Portfolio
  54. 8.9.5 Lead Chemical CO., Ltd Recent Developments
  55. 8.10 Kowa Company
  56. 8.10.1 Kowa Company Company Information
  57. 8.10.2 Kowa Company Business Overview
  58. 8.10.3 Kowa Company OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kowa Company OTC Analgesic Gel Drug Product Portfolio
  60. 8.10.5 Kowa Company Recent Developments
  61. 8.11 Haleon
  62. 8.11.1 Haleon Company Information
  63. 8.11.2 Haleon Business Overview
  64. 8.11.3 Haleon OTC Analgesic Gel Drug Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Haleon OTC Analgesic Gel Drug Product Portfolio
  66. 8.11.5 Haleon Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst